End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.35 EUR | 0.00% | 0.00% | -82.80% |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales 1 | 0.2188 | 0.1204 | - | - | - | - |
EBITDA 1 | -0.2416 | -0.1611 | -0.0887 | -0.371 | -0.1985 | -0.008406 |
EBIT 1 | -0.2446 | -0.1641 | -0.0894 | -0.373 | -0.2015 | -0.1104 |
Operating Margin | -111.79% | -136.33% | - | - | - | - |
Earnings before Tax (EBT) 1 | -0.254 | -0.1654 | -0.4045 | -0.385 | -0.2233 | -0.2364 |
Net income 1 | -0.254 | -0.1654 | -0.4045 | -0.385 | -0.2233 | -0.2364 |
Net margin | -116.08% | -137.39% | - | - | - | - |
EPS 2 | -0.2682 | -0.1746 | -0.4270 | - | -0.2357 | -0.2496 |
Free Cash Flow 1 | -0.1316 | -0.0745 | 0.1056 | 0.5091 | 0.1667 | -0.4146 |
FCF margin | -60.14% | -61.9% | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 02/05/18 | 28/06/19 | 13/08/20 | 05/06/23 | 05/06/23 | 05/06/23 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 0.14 | 0.14 | 0.11 | 0.03 | 0.02 | 0.01 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | -0.13 | -0.07 | 0.11 | 0.51 | 0.17 | -0.41 |
ROE (net income / shareholders' equity) | -11.8% | -8.21% | -23.4% | -28.9% | -21.7% | -29.6% |
ROA (Net income/ Total Assets) | -6.82% | -4.67% | -2.69% | -11% | -5.54% | -3.12% |
Assets 1 | 3.723 | 3.538 | 15.01 | 3.497 | 4.032 | 7.574 |
Book Value Per Share 2 | 2.210 | 2.040 | 1.610 | - | 0.9700 | 0.7200 |
Cash Flow per Share 2 | 0.1500 | 0.1500 | 0.1200 | - | 0.0200 | 0.0100 |
Capex 1 | 0 | 0 | - | 0.01 | - | - |
Capex / Sales | 0.91% | 1.66% | - | - | - | - |
Announcement Date | 02/05/18 | 28/06/19 | 13/08/20 | 05/06/23 | 05/06/23 | 05/06/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-82.80% | 3.89M | |
+26.12% | 49.18B | |
+0.77% | 42.11B | |
+49.96% | 40.37B | |
-5.26% | 28.85B | |
+13.31% | 26.09B | |
-22.48% | 18.71B | |
+8.61% | 13.26B | |
+32.25% | 12.32B | |
+0.39% | 11.99B |
- Stock Market
- Equities
- DBI Stock
- Financials Deutsche Biotech Innovativ AG